Who founded NeuroCept and who are its current executives?

1. Company records show a dissolved UK Neurocept, not an ongoing executive roster

The official UK company register lists NEUROCEPT LIMITED (company number 09882135) with a registered office in Birmingham; that company was incorporated on 20 November 2015 and marked “Dissolved” on 25 April 2017. The Companies House summary does not list an active management team for an operating business under that entry ^[1].

2. Consumer-facing Neurocept supplement sites present a product but omit verifiable leadership details

Multiple commercial sites marketing Neurocept as a cognitive‑support supplement present product claims and launch messaging but do not supply a clear corporate history tying a named founder or a public executive team to the brand. The official product pages emphasize ingredients, benefits, and marketing language rather than a leadership roster ^{[2] [4]}.

3. PR and news wire coverage touts a 2025 market entry without corporate officer names

Press releases distributed in November 2025 (e.g., GlobeNewswire and related placements) position Neurocept as a “new” brain‑support product for the U.S. market and stress formulation and market positioning. These items repeat product messaging but do not identify founders or list current executives responsible for the brand ^{[3] [5]}.

4. Consumer complaints and review threads raise credibility questions but not leadership facts

Trustpilot and other consumer review pages discuss Neurocept in the context of advertising and product claims; some reviewers allege misleading promotions and cite celebrity misuse of likenesses. Those threads critique marketing and product composition but do not reliably identify who founded the company or who currently runs it ^[6].

5. Multiple “Neurocept” names creates brand ambiguity across jurisdictions

The record shows at least two separate usages of the Neurocept name: a dissolved UK private limited company (2015–2017) and one or more modern supplement product sites and press items active in 2024–2025. Sources do not connect the dissolved UK entity to the modern product marketing, nor do they show a continuous corporate lineage or shared executives ^{[1] [2] [3]}.

6. What the available sources do not say — and why that matters

Available sources do not name a founder or list current executives for the supplement-marketed Neurocept product; they also do not show that the UK NEUROCEPT LIMITED entity was tied to the 2025 product launches. The absence of named officers on PR materials and product pages prevents independent verification of who founded or currently leads the operating brand ^{[1] [2] [3]}.

7. How to verify leadership if you need a definitive answer

To establish founders and executives definitively, consult primary corporate filings or regulatory disclosures in the jurisdiction where the trading entity is incorporated (e.g., Companies House for UK entities, state business registries in the U.S., or FDA/FTC records where relevant). Press contact lines on the product site or the press‑release distributor can sometimes provide a corporate contact; none of the sources in this set, however, supplied named founders or an executive list ^{[1] [2] [3]}.

Limitations and competing viewpoints: sources include official company registration data (Companies House) and commercial/PR material (product sites and press releases). The registration data is factual about a dissolved UK company ^[1]. Commercial marketing and PR emphasize product claims and launch timing but omit governance details, which is consistent across the product sites and releases ^{[2] [3]}. Some consumer reviews allege deceptive marketing but do not prove who runs the brand ^[6]. Available sources do not mention a single founder or current executive list for a live Neurocept company ^{[1] [2] [3] [6]}.